TRANSITION AND CONSULTING AGREEMENTTransition and Consulting Agreement • June 19th, 2020 • Obalon Therapeutics Inc • Surgical & medical instruments & apparatus • California
THIS TRANSITION AND CONSULTING AGREEMENT (the “Agreement”) is made and entered into as of June 11, 2020 (the “Effective Date”) by and between Obalon Therapeutics, Inc. (the “Company”) and Amy Vandenberg (“Consultant”).
AMENDED AND RESTATED RETENTION AGREEMENTAmended and Restated Retention Agreement • June 19th, 2020 • Obalon Therapeutics Inc • Surgical & medical instruments & apparatus • California
This Amended and Restated Retention Agreement (the “Agreement”) is entered into by and between Andrew Rasdal (the “Executive”) and Obalon Therapeutics, Inc., a Delaware corporation (the “Company”), effective as of June 9, 2020 (the “Effective Date”). This Agreement amends and restates in its entirety that certain Retention Agreement, dated as of October 10, 2016, by and between the Executive and the Company (the “Original Agreement”). The Executive agrees that, as of the Effective Date, the Original Agreement shall be terminated and of no further force or effect and shall be superseded by this Agreement.
